Pasithea Therapeutics earnings were -$15.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest KTTA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$3.0M, down 22.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, KTTA reported annual earnings of -$16.0M, with 14.5% growth. The next KTTA earnings date is Dec 27, 2024.
Pasithea Therapeutics Earnings Reports & History FAQ
What were Pasithea Therapeutics's earnings last quarter?
On KTTA's earnings call on Invalid Date, Pasithea Therapeutics (NASDAQ: KTTA) reported Q3 2024 earnings per share (EPS) of -$2.87, up 0% year over year. Total KTTA earnings for the quarter were -$3.00 million. In the same quarter last year, Pasithea Therapeutics's earnings per share (EPS) was -$2.87.
The next KTTA earnings date is Invalid Date. Add KTTA to your watchlist to be reminded of Pasithea Therapeutics's next earnings date.
What was KTTA's earnings growth in the past year?
As of Pasithea Therapeutics's earnings date in Invalid Date, Pasithea Therapeutics's earnings has grown year over year. KTTA earnings in the past year totalled -$15.78 million.
Is Pasithea Therapeutics profitable or losing money?
As of the last Pasithea Therapeutics earnings report, Pasithea Therapeutics is currently losing money. Pasithea Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$15.78 million, a 1.6% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.